BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12393381)

  • 21. [Molecular mechanisms in the development of acute myeloid leukemia].
    Ichikawa M; Kurokawa M
    Nihon Rinsho; 2009 Oct; 67(10):1889-93. PubMed ID: 19860185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
    Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormalities of p51, p53, FLT3 and N-ras genes and their prognostic value in relapsed acute myeloid leukemia.
    Nakamura H; Inokuchi K; Yamaguchi H; Dan K
    J Nippon Med Sch; 2004 Aug; 71(4):270-8. PubMed ID: 15329487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Français d'Hématologie Cellulaire (GFHC).
    Duchayne E; Fenneteau O; Pages MP; Sainty D; Arnoulet C; Dastugue N; Garand R; Flandrin G; ;
    Leuk Lymphoma; 2003 Jan; 44(1):49-58. PubMed ID: 12691142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation.
    Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    Blood; 2004 Sep; 104(5):1474-81. PubMed ID: 15142876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH).
    Luquet I; Laï JL; Barin C; Baranger L; Bilhou-Nabera C; Lippert E; Gervais C; Talmant P; Cornillet-Lefebvre P; Perot C; Nadal N; Mozziconacci MJ; Lafage-Pochitaloff M; Eclache V; Mugneret F; Lefebvre C; Herens C; Speleman F; Poirel H; Tigaud I; Cabrol C; Rousselot P; Daliphard S; Imbert M; Garand R; Geneviève F; Berger R; Terre C;
    Leukemia; 2008 Jan; 22(1):132-7. PubMed ID: 17928884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosome 21 tandem repetition and AML1 (RUNX1) gene amplification.
    Ferro MT; Hernaez R; Sordo MT; Garcia-Sagredo JM; Garcia-Miguel P; Fernández Guijarro M; Lopez J; Villalón C; Vallcorba I; Cabello P; San Roman C
    Cancer Genet Cytogenet; 2004 Feb; 149(1):11-6. PubMed ID: 15104277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.
    Tang JL; Hou HA; Chen CY; Liu CY; Chou WC; Tseng MH; Huang CF; Lee FY; Liu MC; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Lin LI; Tien HF
    Blood; 2009 Dec; 114(26):5352-61. PubMed ID: 19808697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New mechanisms of AML1 gene alteration in hematological malignancies.
    Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
    Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aml1/ETO and Pml/RARA rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17).
    Varella-Garcia M; Brizard F; Roche J; Flandrin G; Drabkin H; Brizard A
    Leuk Lymphoma; 1999 Apr; 33(3-4):403-6. PubMed ID: 10221524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.
    Harada H; Harada Y; Tanaka H; Kimura A; Inaba T
    Blood; 2003 Jan; 101(2):673-80. PubMed ID: 12393679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.
    Taketani T; Taki T; Sugita K; Furuichi Y; Ishii E; Hanada R; Tsuchida M; Sugita K; Ida K; Hayashi Y
    Blood; 2004 Feb; 103(3):1085-8. PubMed ID: 14504097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model.
    Grundler R; Miething C; Thiede C; Peschel C; Duyster J
    Blood; 2005 Jun; 105(12):4792-9. PubMed ID: 15718420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH).
    Dastugue N; Lafage-Pochitaloff M; Pagès MP; Radford I; Bastard C; Talmant P; Mozziconacci MJ; Léonard C; Bilhou-Nabéra C; Cabrol C; Capodano AM; Cornillet-Lefebvre P; Lessard M; Mugneret F; Pérot C; Taviaux S; Fenneteaux O; Duchayne E; Berger R;
    Blood; 2002 Jul; 100(2):618-26. PubMed ID: 12091356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.
    Tsukamoto N; Karasawa M; Tanaka Y; Yokohama A; Uchiumi H; Matsushima T; Murakami H; Nojima Y
    Int J Hematol; 2003 Nov; 78(4):362-9. PubMed ID: 14686496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia.
    Cherry AM; Bangs CD; Jones P; Hall S; Natkunam Y
    Cancer Genet Cytogenet; 2001 Sep; 129(2):155-60. PubMed ID: 11566347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.
    Moreno I; Martín G; Bolufer P; Barragán E; Rueda E; Román J; Fernández P; León P; Mena A; Cervera J; Torres A; Sanz MA
    Haematologica; 2003 Jan; 88(1):19-24. PubMed ID: 12551822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.